• Electrovac Q1 revenue rose 12% to EUR 31.5 million; EBIT increased 11% to EUR 3.2 million.
• Adjusted EBIT, excluding one-off IPO costs, more than doubled to EUR 5.4 million.
• Order intake outpaced sales with a 2.3 book-to-bill ratio, led by Aerospace & Defence and Industrials.
• IPO gross proceeds totaled EUR 29.95 million; equity ratio climbed 13.1 percentage points to 68.2%.
• Full-year outlook reaffirmed: revenue EUR 120 million-EUR 130 million; EBIT EUR 11 million-EUR 12 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electrovac AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2389804_en) on August 31, 2026, and is solely responsible for the information contained therein.